Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Europe Finance Weekly.
Press releases published on May 8, 2025
Parex Resources Announces First Quarter Results, Declaration of Q2 2025 Dividend, and Operational Update
GlobeNewswire
·
May 8, 2025
CALGARY, Alberta, May 08, 2025 (GLOBE NEWSWIRE) -- Parex Resources Inc. (“Parex” or the “Company”) (TSX: PXT) is pleased to announce its financial and operating results for the three-month period ended March 31, 2025, the declaration of its Q2 2025 regular …
Studio City International Holdings Limited Announces Unaudited First Quarter 2025 Earnings
GlobeNewswire
·
May 8, 2025
MACAU, May 08, 2025 (GLOBE NEWSWIRE) -- Studio City International Holdings Limited (NYSE: MSC) (“Studio City” or the “Company”), a world-class integrated resort located in Cotai, Macau, today reported its unaudited financial results for the first quarter …
Melco Announces Unaudited First Quarter 2025 Earnings
GlobeNewswire
·
May 8, 2025
MACAU, May 08, 2025 (GLOBE NEWSWIRE) -- Melco Resorts …
BitFuFu Announces April 2025 Bitcoin Mining and Operation Updates
GlobeNewswire
·
May 8, 2025
Total hashrate under management reached 28.3 EH/s as of April 30, 2025, a 37.4% month-over-month increase. Total power capacity under management rose to 566 MW across five continents as of April 30, 2025, an 18.4% month-over-month increase. Bitcoin …
xSuite Group Partners with Trenex Consulting to Expand Global Reach
GlobeNewswire
·
May 8, 2025
Press Release xSuite xSuite Group Partners with Trenex Consulting to Expand Global Reach The Finance Automation consulting firm from the USA will now offer SAP user companies the software solutions of the German specialist for automated P2P processes …
PDS Biotech Announces Additional Details on Two Preclinical Universal Influenza Presentations at IMMUNOLOGY2025™ Annual Meeting
GlobeNewswire
·
May 8, 2025
PRINCETON, N.J., May 08, 2025 (GLOBE NEWSWIRE) -- PDS Biotechnology Corporation (Nasdaq: PDSB) (“PDS Biotech” or the “Company”), a late-stage immunotherapy company focused on transforming how the immune system targets and kills cancers and infectious …
Protara Therapeutics Announces First Quarter 2025 Financial Results and Provides Business Update
GlobeNewswire
·
May 8, 2025
Reported positive interim results demonstrating durable responses in the ongoing Phase 2 ADVANCED-2 trial of TARA-002 in NMIBC Results from planned interim analysis of approximately 25 six-month evaluable BCG-Unresponsive patients expected by the end of …
BermudAir Partners with Zero Hash to Launch First-of-Its-Kind Stablecoin Payments in Air Travel
GlobeNewswire
·
May 8, 2025
HAMILTON, Bermuda, May 08, 2025 (GLOBE NEWSWIRE) -- BermudAir, Bermuda’s first homegrown airline, today announced a groundbreaking partnership with Zero Hash to let customers purchase flights with stablecoins as part of the standard booking flow by the end …
Artiva Biotherapeutics Reports First Quarter 2025 Financial Results, Recent Business Highlights
GlobeNewswire
·
May 8, 2025
IND clearance and initiation of global basket trial exploring AlloNK® + rituximab in refractory rheumatoid arthritis, Sjögren’s disease, idiopathic inflammatory myopathies and systemic sclerosis First trial to explore an allogeneic cell therapy in …
Obra Capital Announces Promotion of Peter Polanskyj to Chief Investment Officer
GlobeNewswire
·
May 8, 2025
NEW YORK, May 08, 2025 (GLOBE NEWSWIRE) -- Obra Capital, Inc. (along with its affiliated registered investment advisors, collectively “Obra”), an asset management firm with a specialized approach to alternative investing, today announced that Peter …
NewAmsterdam Pharma Provides Corporate Update and Reports First Quarter Financial Results
GlobeNewswire
·
May 8, 2025
– EMA submission expected in 2H25 by partner Menarini – – PREVAIL Phase 3 CVOT remains on track – -- BROADWAY and TANDEM results presented at EAS with simultaneous publications in the New England Journal of Medicine and The Lancet, respectively -- -- …
Capital Clean Energy Carriers Corp. Announces First Quarter 2025 Financial Results and Employment for Two LNG Carriers ("LNG/C") Under Construction
GlobeNewswire
·
May 8, 2025
ATHENS, Greece, May 08, 2025 (GLOBE NEWSWIRE) -- Capital Clean Energy Carriers Corp. (the “Company,” “CCEC”, “we” or “us”) (NASDAQ: CCEC), an international owner of ocean-going vessels, today released its financial results for the first quarter ended March …
Compass Therapeutics Reports 2025 First Quarter Financial Results and Provides Corporate Update
GlobeNewswire
·
May 8, 2025
Tovecimig (DLL4 x VEGF-A bispecific antibody) met the primary endpoint in the ongoing randomized Phase 2/3 Study in patients with biliary tract cancer (BTC). Achieved a 17.1% overall response rate (ORR), including one complete response, compared to a 5.3% …
D-BOX and Cinemark Announce Expansion with the Addition of Over 70 New D-BOX Haptic-Enabled Screens
GlobeNewswire
·
May 8, 2025
MONTREAL, May 08, 2025 (GLOBE NEWSWIRE) -- D-BOX Technologies Inc. (“D-BOX” or the "Corporation") (TSX: DBO), a Corporation with more than 25 years of experience creating haptic and immersive experiences, is proud to announce an expansion of its long- …
D-BOX et Cinemark annoncent une expansion avec l’ajout de plus de 70 nouvelles salles équipées de la technologie haptique D-BOX
GlobeNewswire
·
May 8, 2025
MONTRÉAL, 08 mai 2025 (GLOBE NEWSWIRE) -- Technologies D-BOX inc. (« D-BOX » ou la « Société ») (TSX : DBO), une entreprise comptant plus de 25 ans d’expérience dans la création d’expériences haptiques et immersives, est fière d’annoncer une nouvelle phase …
Stryker declares an $0.84 per share quarterly dividend
GlobeNewswire
·
May 8, 2025
Portage, Michigan, May 08, 2025 (GLOBE NEWSWIRE) -- Stryker (NYSE:SYK) announced that its Board of Directors has declared a quarterly dividend of $0.84 per share payable July 31, 2025, to shareholders of record at the close of business on June 30, 2025, …
RAPT Therapeutics Reports First Quarter 2025 Financial Results
GlobeNewswire
·
May 8, 2025
SOUTH SAN FRANCISCO, Calif., May 08, 2025 (GLOBE NEWSWIRE) -- RAPT Therapeutics, Inc. (Nasdaq: RAPT) (“RAPT” or the “Company”), a clinical-stage immunology-based biopharmaceutical company focused on discovering, developing and commercializing novel …
Perma-Fix Reports Q1 2025 Results and Highlights Momentum in Hanford and PFAS Programs
GlobeNewswire
·
May 8, 2025
Improved gross margins and rising backlog driven by increased waste receipts Strategic investments expected to position the Company for stronger performance in the second half of 2025 ATLANTA, May 08, 2025 (GLOBE NEWSWIRE) -- Perma-Fix Environmental …
Cassava Reports Q1 2025 Financials Results, Provides Business Update
GlobeNewswire
·
May 8, 2025
License agreement and recent leadership appointments position Cassava to advance development of simufilam in TSC-related epilepsy $117.3 Million in Cash and Cash Equivalents at March 31, 2025 AUSTIN, Texas, May 08, 2025 (GLOBE NEWSWIRE) -- Cassava Sciences …
Core Molding Technologies Reports Fiscal 2025 First Quarter Results
GlobeNewswire
·
May 8, 2025
COLUMBUS, Ohio, May 08, 2025 (GLOBE NEWSWIRE) -- Core Molding Technologies, Inc. (NYSE American: CMT) (“Core Molding”, “Core” or the “Company”), a leading engineered materials company specializing in molded structural products, principally in building …